- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02568774
Acupuncture on Post-Stroke Overactive Bladder
October 10, 2018 updated by: Dr. Haiyong Chen, The University of Hong Kong
Acupuncture on Post-Stroke Overactive Bladder: A Randomized Controlled Trial
This study evaluates the effect of acupuncture on post-stroke overactive bladder symptoms.
Participants will be put into groups randomly and compared.
There are two groups: traditional acupuncture and usual care.
The ratio of group allocation is 1:1.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Current practice in management of OAB is quite limited.
Acupuncture, which is a major treatment modality of traditional Chinese medicine, has also claimed to have favourable therapeutic effect on OAB.
Previous study found that acupuncture at the BL-33 point was effective for controlling the overactive bladder.
Although acupuncture has been shown to be effective in treating OAB, there has been no randomized controlled trial examining the efficacy of acupuncture on patients with post-stroke.
Given the high incidence of OAB in post-stroke patients, potentially effective alternative treatments should be investigated.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chinese aged 18 or above
- Patient suffering from first ever stroke or recurrent stroke with no urinary symptom in previous episode(s);
- Patient with classic symptoms, i.e. urgency, urinary frequency or urge incontinence and Overactive Bladder Symptom Score (OABSS) score ≥3 and the urgency item rated as at least 2-point;
- Not taking any medication for OAB
- Able to communicate
- No current acupuncture or transcutaneous electrical nerve stimulation treatment
Exclusion Criteria:
- Urinary retention with post-void urinary volume > 100ml;
- Current urinary tract infection;
- Preexisting history of OAB or bladder outlet obstruction or underactive bladder;
- Significant cognitive impairment with MMSE < or =19;
- Coexisting Alzheimer's disease, Parkinson's disease, spinal cord disorder or progressive neurological disease such as multiple sclerosis;
- Active skin lesion or open wound over the needle placement areas;
- Having valvular heart defects, severe cardiac diseases, or bleeding disorders,
- Being fitted with any implanted electrical device such as pacemaker, defibrillator, or brain stimulation;
- Pregnant;
- Malignancies at the sites of selected acupoints;
- Receiving acupuncture treatment 1 month before baseline.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Traditional Acupuncture
Acupoints which are empirical for treating OAB in terms of Traditional Chinese medicine theory are used (in the sequence of scalp reproduction area and motor area of the unaffected side, RN3, bilateral BL32, BL33, BL28, BL39).
And Ear point urinary bladder, and Ear point uterus will be treated after removal of needles.
Needles will be left for 30 minutes and then removed.
Subjects will be treated with acupuncture 2 times per week for the first 2 weeks and 1 per week for the 3rd and 4th week.
|
Treatment is based on the traditional Chinese medicine theory for treating overactive bladder.
Qi-transforming function of bladder is regulated by experienced Chinese medicine practitioner.
|
|
Other: Usual Care
Patients will receive conventional rehabilitation as usual, including standard physiotherapy, bladder training and general advise of fluid intake.
|
Patients will receive conventional rehabilitation as usual, including standard physiotherapy, bladder training and general advise of fluid intake.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overactive Bladder Symptom Scale (OABSS)
Time Frame: 1-week posttreatment
|
four item questionnaire quantifies overactive bladder symptoms in a single score
|
1-week posttreatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of incontinent episodes measured by bladder diary
Time Frame: 1-week posttreatment, 4-week posttreatment
|
Record the frequency of day and night time voiding and incontinence episodes over 3 day periods
|
1-week posttreatment, 4-week posttreatment
|
|
Stroke Specific Quality of Life Scale (SS-QoLS)
Time Frame: 1-week posttreatment, 4-week posttreatment
|
12 items questionnaire consists of physical and psychosocial subscales: amount of help required completing a task, trouble experienced performing a task and functioning.
|
1-week posttreatment, 4-week posttreatment
|
|
Medication measured by bladder diary
Time Frame: 1-week posttreatment, 4-week posttreatment
|
number of patients requested medication for OAB from bladder diary.
|
1-week posttreatment, 4-week posttreatment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
AE measured by open-ended questions
Time Frame: first week of treatment, second week of treatment, third week of treatment, 1-week posttreatment, 4-week posttreatment
|
open-ended questions about the experience of adverse events
|
first week of treatment, second week of treatment, third week of treatment, 1-week posttreatment, 4-week posttreatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Wing Fai Yeung, BCM, PhD, The University of Hong Kong
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
August 1, 2018
Study Completion (Actual)
August 1, 2018
Study Registration Dates
First Submitted
June 13, 2015
First Submitted That Met QC Criteria
October 4, 2015
First Posted (Estimate)
October 6, 2015
Study Record Updates
Last Update Posted (Actual)
October 11, 2018
Last Update Submitted That Met QC Criteria
October 10, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AcupPSOAB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overactive Bladder
-
Ankara Yildirim Beyazıt UniversityCompletedOveractive Bladder | Overactive Detrusor | Overactive Bladder SyndromeTurkey
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Medstar Health Research InstituteColumbia University; University of Michigan; University of New Mexico; Methodist...Terminated
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Merck Sharp & Dohme LLCTerminatedOveractive Bladder | Overactive Urinary Bladder
-
Loyola UniversityAstellas Pharma IncCompletedOveractive Bladder SyndromeUnited States
-
Beijing Pins Medical Co., LtdUnknown
-
Maastricht University Medical CenterUnknownLower Urinary Tract Symptoms | Overactive Bladder SyndromeNetherlands
-
Pamukkale UniversityCompletedElectrical Stimulation | Idiopathic Overactive Bladder | Bladder TrainingTurkey
Clinical Trials on Traditional Acupuncture
-
University of MichiganMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
Brigham and Women's HospitalMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
Cedars-Sinai Medical CenterNational Center for Complementary and Integrative Health (NCCIH)CompletedCoronary Artery DiseaseUnited States
-
Beijing University of Chinese MedicineXiyuan Hospital of China Academy of Chinese Medical SciencesCompletedChemotherapy-induced Nausea and VomitingChina
-
The University of Hong KongNational Center for Complementary and Integrative Health (NCCIH)Unknown
-
Beijing University of Chinese MedicineGuang'anmen Hospital of China Academy of Chinese Medical Sciences; Xiyuan Hospital... and other collaboratorsCompletedChemotherapy-induced Nausea and VomitingChina
-
VA Office of Research and DevelopmentAnalydata, IncCompleted
-
Qilu Hospital of Shandong UniversityWeifang Yidu Central Hospital; The People's Hospital of Yinan CountyRecruitingGastroparesis Postoperative | Delayed Gastric Emptying Following ProcedureChina
-
Cairo UniversityCompletedPatellofemoral Pain SyndromeEgypt
-
University of British ColumbiaUnknown